2001-2010 to 2011-2022 Saw Rise in Incidence of Zoonotic Disease Tularemia
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
THURSDAY, Jan. 2, 2025 -- The incidence of tularemia, a rare nationally notifiable zoonosis caused by Francisella tularensis, increased from 2001-2010 to 2011-2022, according to research published in the Jan. 2 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.
Shannan N. Rich, Ph.D., from the CDC in Atlanta, and colleagues describe tularemia cases in the United States during 2011 to 2022.
The researchers note that 47 states reported 2,462 cases of tularemia during 2011 to 2022, and four states (Arkansas, Kansas, Missouri, and Oklahoma) accounted for 50 percent of all reported cases. The incidence was highest among children aged 5 to 9 years and in men aged 65 to 84 years (0.083 per 100,000 population and 0.133 to 0.161 per 100,000 population, respectively). Incidence was approximately five times higher in American Indian or Alaska Native persons versus White persons (0.260 versus 0.057). During 2011 to 2022, the average annual incidence of tularemia was 56 percent higher than that reported during 2001 to 2010 (0.064 and 0.041, respectively), mainly due to increased reporting of probable cases.
"The findings in this report highlight the need for tailored prevention education given the myriad of potential exposures to F. tularensis in the environment, including via inhalation, ingestion, contact with animals, or arthropod bites," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2025-01-03 12:00
Read more
- Study IDs Specific Anaphylactic Triggers Linked to Symptoms, Treatment
- FDA Approves Opdivo Qvantig (nivolumab and hyaluronidase-nvhy) Subcutaneous Injection for Use in Most Previously Approved Solid Tumor Opdivo (nivolumab) Indications
- Newer Drug Could Be Advance Against Tough-to-Treat Breast Cancers
- More Activity, Less Risk: Tell Your MD How Much You Move
- Tolebrutinib Designated Breakthrough Therapy by the FDA for Non-Relapsing Secondary Progressive Multiple Sclerosis
- FDA Approves Ryoncil (remestemcel-L-rknd) Mesenchymal Stromal Cell Therapy for Steroid-Refractory Acute Graft Versus Host Disease
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions